公司概覽
業務類別 Biotechnology
業務概覽 Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
公司地址 1851 Harbor Bay Parkway, Alameda, CA, USA, 94502
電話號碼 +1 650 837-7000
傳真號碼 +1 650 837-8300
公司網頁 https://www.exelixis.com
員工數量 4600
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Michael M. Morrissey, PhD Director, President and Chief Executive Officer 美元 1.31M 15/04/2026
Mr. Christopher J. Senner Executive Vice President, Chief Financial Officer and Principal Accounting Officer 美元 822.82K 15/04/2026
Mr. Patrick J. Haley Executive Vice President, Commercial 美元 621.32K 15/04/2026
Dr. Dana T. Aftab, PhD Executive Vice President, Research and Development 美元 659.06K 15/04/2026
Dr. Brenda Hefti, J.D.,PhD Senior Vice President and General Counsel 美元 454.55K 15/04/2026
 
董事會成員
董事會 職務 更新日期
Dr. George H. Poste, D.V.M.,F.R.S.,PhD Independent Director 15/04/2026
Mr. Jack L. Wyszomierski, M.S. Independent Director 15/04/2026
Dr. Michael M. Morrissey, PhD Director, President and Chief Executive Officer 15/04/2026
Dr. Stelios Papadopoulos,PhD Chairman of the Board 15/04/2026
Mr. David E. Johnson Independent Director 15/04/2026
Dr. Mary C. Beckerle, PhD Independent Director 15/04/2026
Dr. Maria C. Freire, PhD Independent Director 15/04/2026
Ms. Julie Anne Smith Independent Director 15/04/2026
Mr. Tomas J. Heyman Independent Director 15/04/2026
Dr. Sue Gail Eckhardt, M.D. Independent Director 15/04/2026
Mr. Robert Oliver, M.B.A. Independent Director 15/04/2026
 
所屬ETF (更新日期: 14/11/2026 04:17)
代號 名稱 佔比% ▼ 持有日期
EQALInvesco Russell 1000 Equal Weight ETF0.01%30/10/2026
VAMOCambria Value and Momentum ETF0.01%30/10/2026
AVUQAvantis U.S. Quality ETF0.01%30/10/2026
SMDXIntech S&P Small-Mid Cap Divers Alp ETF0.01%30/10/2026
EBILongview Advantage ETF0.005%30/10/2026
PTLInspire 500 ETF0.005%30/10/2026
GVLUGotham 1000 Value ETF0.005%30/10/2026
NEWZStockSnips AI-Powered Sen US ALL Cp ETF0.005%30/10/2026
BFORBarron's 400 ETF0.004%31/10/2026
IYYiShares Dow Jones US ETF0.004%30/10/2026
TILTNorthern Trust Mstar US Mkt Fac Tlt ETF0.004%30/10/2026
FELGFidelity Enhanced Large Cap Growth ETF0.004%30/10/2026
SUREAdvisorShares Insider Advantage ETF0.004%30/10/2026
MSLCMorgan Stanley Pathway Large Cap Eq ETF0.004%31/10/2026
AVSUAvantis Responsible US Equity ETF0.004%30/10/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF0.004%31/10/2026
MSMLiShares MSCI USA Small-Cap ETF0.004%30/10/2026
SMOXHorizon Small/Mid Cap Core Equity ETF0.004%30/10/2026
BIBProShares Ultra Nasdaq Biotechnology0.004%30/10/2026
MVVProShares Ultra MidCap4000.003%30/10/2026
  1    2    3    4    5    6    7   8    9    10    11    12    13  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.